Eosinophilic inflammation assessed by induced sputum in corticosteroid-dependent asthma.

PubWeight™: 0.79‹?›

🔗 View Article (PMID 10464876)

Published in Respir Med on March 01, 1999

Authors

P Tarodo de la Fuente1, M Romagnoli, L Carlsson, P Godard, J Bousquet, P Chanez

Author Affiliations

1: Service des Maladies Respiratoires, INSERM U454, Hôpital Arnaud de Villeneuve, Montpellier, France.

Articles by these authors

Insulin-promoter-factor 1 is required for pancreas development in mice. Nature (1994) 10.13

Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J (2008) 10.08

Eosinophilic inflammation in asthma. N Engl J Med (1990) 8.05

Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development. Cardiovasc Res (2003) 5.39

A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force. Allergy (2001) 5.07

A new highly penetrant form of obesity due to deletions on chromosome 16p11.2. Nature (2010) 4.52

Actin polymerizability is influenced by profilin, a low molecular weight protein in non-muscle cells. J Mol Biol (1977) 4.31

Selective assay of monomeric and filamentous actin in cell extracts, using inhibition of deoxyribonuclease I. Cell (1978) 3.74

Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE. Allergy (2005) 3.22

A new perspective on concepts of asthma severity and control. Eur Respir J (2008) 3.16

Roentgen stereophotogrammetric analysis as a predictor of mechanical loosening of knee prostheses. J Bone Joint Surg Br (1995) 3.00

Difficult/therapy-resistant asthma: the need for an integrated approach to define clinical phenotypes, evaluate risk factors, understand pathophysiology and find novel therapies. ERS Task Force on Difficult/Therapy-Resistant Asthma. European Respiratory Society. Eur Respir J (1999) 2.96

Induction of nitric oxide synthase in asthma. Lancet (1994) 2.93

Clinical COPD phenotypes: a novel approach using principal component and cluster analyses. Eur Respir J (2010) 2.77

Standards for practical allergen-specific immunotherapy. Allergy (2006) 2.70

Transforming growth factor-beta expression in mucosal biopsies in asthma and chronic bronchitis. Am J Respir Crit Care Med (1997) 2.47

Glucocorticoid receptor alpha and beta in glucocorticoid dependent asthma. Am J Respir Crit Care Med (2000) 2.36

Sputum metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio correlates with airflow obstruction in asthma and chronic bronchitis. Am J Respir Crit Care Med (1998) 2.36

Unmet clinical needs in chronic spontaneous urticaria. A GA²LEN task force report. Allergy (2010) 2.34

Phylogeny of nitrogenase sequences in Frankia and other nitrogen-fixing microorganisms. J Mol Evol (1989) 2.33

Anti-actin specificity of human smooth muscle antibodies in chronic active hepatitis. Clin Exp Immunol (1976) 2.24

Cost-effectiveness of omalizumab in patients with severe persistent allergic asthma. Allergy (2007) 2.22

Chronic rhinosinusitis in Europe--an underestimated disease. A GA²LEN study. Allergy (2011) 2.13

Instability and triangulation of the action potential predict serious proarrhythmia, but action potential duration prolongation is antiarrhythmic. Circulation (2001) 2.11

Quality of life in allergic rhinitis and asthma. A population-based study of young adults. Am J Respir Crit Care Med (2000) 2.08

Pro: Immunotherapy is clinically indicated in the management of allergic asthma. Am J Respir Crit Care Med (2001) 2.04

Reorganization of actin in platelets stimulated by thrombin as measured by the DNase I inhibition assay. Proc Natl Acad Sci U S A (1979) 2.02

Grading quality of evidence and strength of recommendations in clinical practice guidelines. Part 1 of 3. An overview of the GRADE approach and grading quality of evidence about interventions. Allergy (2009) 1.97

Desmin is essential for the tensile strength and integrity of myofibrils but not for myogenic commitment, differentiation, and fusion of skeletal muscle. J Cell Biol (1997) 1.94

Eosinophilic and neutrophilic inflammation in asthma, chronic bronchitis, and chronic obstructive pulmonary disease. J Allergy Clin Immunol (1993) 1.91

Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review. Growth Hormone Research Society Scientific Committee. J Clin Endocrinol Metab (1998) 1.89

Sputum induction. Eur Respir J Suppl (2002) 1.88

Corticosteroid reversibility in COPD is related to features of asthma. Am J Respir Crit Care Med (1997) 1.87

Drugs that may injure the respiratory system. Eur Respir J (1997) 1.86

Efficacy and safety of a recombinant anti-immunoglobulin E antibody (omalizumab) in severe allergic asthma. Clin Exp Allergy (2004) 1.84

Lung function and asthma control with beclomethasone and formoterol in a single inhaler. Respir Med (2008) 1.82

Continuing high early death rate in acute promyelocytic leukemia: a population-based report from the Swedish Adult Acute Leukemia Registry. Leukemia (2011) 1.79

Costs of asthma are correlated with severity: a 1-yr prospective study. Eur Respir J (2002) 1.79

Emergency treatment of allergic reactions to Hymenoptera stings. Clin Exp Allergy (1991) 1.76

Recommendations for standardization of clinical trials with Allergen Specific Immunotherapy for respiratory allergy. A statement of a World Allergy Organization (WAO) taskforce. Allergy (2007) 1.75

Genome screen for asthma and related phenotypes in the French EGEA study. Am J Respir Crit Care Med (2000) 1.75

Axonemal dynein intermediate-chain gene (DNAI1) mutations result in situs inversus and primary ciliary dyskinesia (Kartagener syndrome). Am J Hum Genet (2001) 1.75

Upper airway x 1: allergic rhinitis and asthma: united disease through epithelial cells. Thorax (2009) 1.74

GA(2)LEN skin test study I: GA(2)LEN harmonization of skin prick testing: novel sensitization patterns for inhalant allergens in Europe. Allergy (2009) 1.72

Rhinosinusitis in severe asthma. J Allergy Clin Immunol (2001) 1.72

Asthma in adults and its association with chronic rhinosinusitis: the GA2LEN survey in Europe. Allergy (2011) 1.71

A survey of the burden of allergic rhinitis in Europe. Allergy (2007) 1.71

Allergen immunotherapy: therapeutic vaccines for allergic diseases. World Health Organization. American academy of Allergy, Asthma and Immunology. Ann Allergy Asthma Immunol (1998) 1.70

Airway remodelling assessed by sputum and high-resolution computed tomography in asthma and COPD. Eur Respir J (2004) 1.70

Airway inflammation in mild intermittent and in persistent asthma. Am J Respir Crit Care Med (1998) 1.69

Frequent exacerbators--a distinct phenotype of severe asthma. Clin Exp Allergy (2014) 1.69

Evaluation of apoptosis of eosinophils, macrophages, and T lymphocytes in mucosal biopsy specimens of patients with asthma and chronic bronchitis. J Allergy Clin Immunol (1999) 1.68

Inhaler competence in asthma: common errors, barriers to use and recommended solutions. Respir Med (2012) 1.68

Postoperative inflammatory response after autologous and allogeneic blood transfusion. Anesthesiology (1997) 1.67

Measurement of the internal size of bronchi using high resolution computed tomography (HRCT) Eur Respir J (1994) 1.67

Chloroplast and nuclear gene sequences indicate late Pennsylvanian time for the last common ancestor of extant seed plants. Proc Natl Acad Sci U S A (1994) 1.66

Iatrogenic eosinophilic pleural effusion. Eur Respir Rev (2011) 1.63

Visual analog scales can assess the severity of rhinitis graded according to ARIA guidelines. Allergy (2007) 1.63

Cost-effectiveness of asthma control: an economic appraisal of the GOAL study. Allergy (2006) 1.62

Efficacy and tolerability of anti-immunoglobulin E therapy with omalizumab in patients with concomitant allergic asthma and persistent allergic rhinitis: SOLAR. Allergy (2004) 1.61

Anti-immunoglobulin E treatment with omalizumab in allergic diseases: an update on anti-inflammatory activity and clinical efficacy. Clin Exp Allergy (2005) 1.59

Molecular evolution of angiosperm mitochondrial introns and exons. Proc Natl Acad Sci U S A (1997) 1.56

Safety and efficacy of a CXCR2 antagonist in patients with severe asthma and sputum neutrophils: a randomized, placebo-controlled clinical trial. Clin Exp Allergy (2012) 1.55

The heparin-binding domain of extracellular superoxide dismutase C and formation of variants with reduced heparin affinity. J Biol Chem (1992) 1.55

The role of transbronchial biopsy in the diagnosis of diffuse parenchymal lung diseases: pro. Rev Port Pneumol (2011) 1.54

[Smoking habits, attitudes and knowledges of medical students of Medicine, Pharmacy and Odonto-Stomatology's Faculty of Dakar, Senegal]. Rev Mal Respir (2003) 1.54

Is bronchial hyperresponsiveness more frequent in women than in men? A population-based study. Am J Respir Crit Care Med (1997) 1.54

Visual analogue scale in patients treated for allergic rhinitis: an observational prospective study in primary care: asthma and rhinitis. Clin Exp Allergy (2013) 1.54

Increased release of matrix metalloproteinase-9 in bronchoalveolar lavage fluid and by alveolar macrophages of asthmatics. Am J Respir Cell Mol Biol (1997) 1.53

Grading quality of evidence and strength of recommendations in clinical practice guidelines: Part 2 of 3. The GRADE approach to grading quality of evidence about diagnostic tests and strategies. Allergy (2009) 1.53

GA(2)LEN skin test study II: clinical relevance of inhalant allergen sensitizations in Europe. Allergy (2009) 1.51

Consensus statement on the treatment of allergic rhinitis. European Academy of Allergology and Clinical Immunology. Allergy (2000) 1.50

Update on severe asthma: what we know and what we need. Eur Respir Rev (2009) 1.50

Precision of skin prick and puncture tests with nine methods. J Allergy Clin Immunol (1991) 1.50

Perennial rhinitis: An independent risk factor for asthma in nonatopic subjects: results from the European Community Respiratory Health Survey. J Allergy Clin Immunol (1999) 1.50

Life-threatening food allergy in a child treated with FK506. J Pediatr Gastroenterol Nutr (1997) 1.49

Novel method for processing respiratory specimens for detection of mycobacteria by using C18-carboxypropylbetaine: blinded study. J Clin Microbiol (1998) 1.48

Chronic respiratory diseases in developing countries: the burden and strategies for prevention and management. Bull World Health Organ (2001) 1.48

Alignments and clinical results in conventional and navigated total knee arthroplasty. Clin Orthop Relat Res (2007) 1.46

Viruses and bacteria in acute asthma exacerbations--a GA² LEN-DARE systematic review. Allergy (2010) 1.45

Epidemiology of cypress pollen allergy in Montpellier. J Investig Allergol Clin Immunol (2012) 1.45